https://pbs.twimg.com/media/Fg44woIXoAQrYau.jpg
Johnson et al TYK2i deucravacitinib does not inhibit haematologic pathways, Treg function, or IL-15 dependent NK cell function, that JAKi do. @rheumnow #ACR22 Abstr#0584 https://t.co/UTHzUjGmJN https://t.co/NUKKAv3tAr

Links:

Non-Clinical Evaluations of Deucravacitinib and Janus Kinase Inhibitor Specific… https://acrabstracts.org/abstract/non-clinical-evaluations-of-deucravacitinib-a…
Richard Conway
RichardPAConway
13-11-2022
×